DaVita Inc. (NYSE: DVA), a stalwart in the healthcare sector, operates at the forefront of providing essential kidney dialysis services across the United States. With a market capitalization of $10.08..
Cytokinetics, Incorporated (NASDAQ: CYTK) is a prominent player in the healthcare sector, specifically within the biotechnology industry. Headquartered in South San Francisco, California, the company is dedicated to the discovery,..
For investors keeping a close watch on the biotechnology sector, Vaxcyte, Inc. (NASDAQ: PCVX) presents a compelling case. With a market capitalization of approximately $7.93 billion, this United States-based healthcare..
Penumbra, Inc. (NASDAQ: PEN), a leading player in the medical devices industry, has captured investor attention with its robust market cap of $13.19 billion and impressive revenue growth of 22.10%...
Illumina, Inc. (NASDAQ: ILMN), a powerhouse in the healthcare sector, is a leader in diagnostics and research with a market capitalization of $18.19 billion. Headquartered in San Diego, California, the..
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands at the forefront of biopharmaceutical innovation, focusing on rare neuroendocrine diseases with its pioneering product, IMCIVREE (setmelanotide). With a market cap of $5.97 billion,..
Teva Pharmaceutical Industries Limited (NYSE: TEVA) is a major player in the healthcare sector, specializing in both specialty and generic drug manufacturing. With its headquarters in Tel Aviv-Yafo, Israel, Teva..
Inspire Medical Systems, Inc. (NASDAQ: INSP), a key player in the medical devices industry, has been making waves with its innovative solutions for obstructive sleep apnea (OSA). Headquartered in Golden..
In the fast-evolving world of diagnostics and research, Qiagen N.V. (NASDAQ: QGEN) stands as a prominent player with a market capitalization of $8.37 billion. Headquartered in Venlo, Netherlands, this healthcare..
Boston Scientific Corporation (NYSE: BSX) is a heavyweight in the healthcare sector, specifically within the medical devices industry. With a commanding market cap of $102.58 billion, this U.S.-based company has..
Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector with its innovative approach to combating RAS-addicted cancers. With a market capitalization of $18.8 billion, this clinical-stage precision..
Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, operates within the medical care facilities industry. Based in Bannockburn, Illinois, the company specializes in providing home..
Revvity, Inc. (NYSE: RVTY), a stalwart in the healthcare diagnostics landscape, has captured investor interest with its intriguing blend of robust product offerings and a significant potential upside of nearly..
CVS Health Corporation (NYSE: CVS), a prominent player in the healthcare sector, is capturing investor attention with a compelling 26.76% potential upside, according to analyst consensus. With a robust market..
Sarepta Therapeutics, Inc. (NASDAQ: SRPT) has long been a beacon of hope in the biotechnology sector, primarily focusing on innovative treatments for rare diseases such as Duchenne Muscular Dystrophy (DMD)...
Natera, Inc. (NTRA), a leader in the diagnostics and research industry, has caught the attention of investors with its promising growth metrics and robust market position. Headquartered in Austin, Texas,..
Insulet Corporation (NASDAQ: PODD), a leading player in the medical devices sector, presents a compelling opportunity for investors seeking growth in the healthcare industry. With a market capitalization of $15.48..
Prestige Consumer Healthcare Inc. (PBH), a key player in the healthcare sector’s drug manufacturing niche, presents a compelling opportunity for investors seeking exposure to the over-the-counter (OTC) health and personal..
Elanco Animal Health Incorporated (NYSE: ELAN) stands as a formidable player in the healthcare sector, particularly within the niche of drug manufacturing for both specialty and generic animal health products...
Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans sector, presents an intriguing opportunity for investors, highlighted by a potential upside of 28.25% according to analyst ratings. As..
